Dexmedetomidine's effect on intraoperative SSEP and MEP monitoring is best described as:
-
A
Profound suppression requiring cessation before monitoring
-
B
Mild to moderate amplitude reduction with relative preservation at typical clinical doses
-
C
Complete abolition of cortical potentials
-
D
No measurable effect on any evoked potential